Parsons Capital Management Inc Amylyx Pharmaceuticals, Inc. Transaction History
Parsons Capital Management Inc
- $1.8 Billion
- Q4 2024
A detailed history of Parsons Capital Management Inc transactions in Amylyx Pharmaceuticals, Inc. stock. As of the latest transaction made, Parsons Capital Management Inc holds 21,645 shares of AMLX stock, worth $79,220. This represents 0.0% of its overall portfolio holdings.
Number of Shares
21,645
Previous 21,945
1.37%
Holding current value
$79,220
Previous $71,000
14.08%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding AMLX
# of Institutions
141Shares Held
48.9MCall Options Held
281KPut Options Held
438K-
Perceptive Advisors LLC New York, NY6.77MShares$24.8 Million0.85% of portfolio
-
Tcg Crossover Management, LLC Palo Alto, CA4.64MShares$17 Million2.86% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.69MShares$9.85 Million0.0% of portfolio
-
Black Rock Inc. New York, NY2.67MShares$9.77 Million0.0% of portfolio
-
Bank Of America Corp Charlotte, NC2.43MShares$8.88 Million0.0% of portfolio
About Amylyx Pharmaceuticals, Inc.
- Ticker AMLX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 58,533,200
- Market Cap $214M
- Description
- Amylyx Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, engages in developing various therapeutics for amyotrophic lateral sclerosis (ALS) and other neurodegenerative diseases. The company's product pipeline includes AMX0035, a dual UPR-Bax apoptosis inhibitor composed of sodium phenylbutyrate and taurursodiol for the treatment...